Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Seizure; and very common findings: Delayed ability to sit and Epileptic encephalopathy. 31 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Dystonia, Seizure, Enlarged brain ventricles (ventriculomegaly) |
Muscles | 2 | Generalized hypotonia, Axial hypotonia |
Head and neck | 2 | Thick lower lip vermilion, Microcephaly |
Bones and joints | 1 | Severe backward arching of the body (opisthotonus) |
Digestive system | 1 | Gastrostomy tube feeding in infancy |
Eyes | 1 | Ptosis |
UGDH function has not been fully characterized.
Developmental and epileptic encephalopathy, 84 is associated with mutations in the UGDH gene on chromosome 4.
Genetic testing for UGDH is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for developmental and epileptic encephalopathy, 84 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 2 very common features, 5 common features.
No clinical trials have been registered for developmental and epileptic encephalopathy, 84.
40 publications have been identified in PubMed for developmental and epileptic encephalopathy, 84. Kisho has analyzed 28 by research type. Research spans Epidemiology / Natural History (32%), Diagnostic / Biomarker (21%), and Review / Meta-Analysis (21%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 9 | 32% |
Testing and diagnosis research | 6 | 21% |
Research summaries | 6 | 21% |
Clinical study results | 4 | 14% |
Laboratory research | 2 | 7% |
New treatment approaches | 1 | 4% |
Kansal B (2026). [PMID: 41498396](https://pubmed.ncbi.nlm.nih.gov/41498396/). *Mov Disord Clin Pract*. [Diagnostic / Biomarker]
Harwood H (2026). [PMID: 42061477](https://pubmed.ncbi.nlm.nih.gov/42061477/). *Matrix Biol*. [Basic Science / Preclinical]
van Arnhem MML (2026). [PMID: 41133317](https://pubmed.ncbi.nlm.nih.gov/41133317/). *Epilepsia*. [Epidemiology / Natural History]
Hou H (2025). [PMID: 40593860](https://pubmed.ncbi.nlm.nih.gov/40593860/). *NPJ Genom Med*. [Diagnostic / Biomarker]
Samanta D (2025). [PMID: 41106086](https://pubmed.ncbi.nlm.nih.gov/41106086/). *Epilepsy Behav*. [Review / Meta-Analysis]
Ramantani G (2025). [PMID: 40152452](https://pubmed.ncbi.nlm.nih.gov/40152452/). *Epilepsia*. [Epidemiology / Natural History]
DeGasperis S (2025). [PMID: 40849994](https://pubmed.ncbi.nlm.nih.gov/40849994/). *Epilepsy Res*. [Clinical Trial Publication]
Dhindsa RS (2025). [PMID: 40015282](https://pubmed.ncbi.nlm.nih.gov/40015282/). *Am J Hum Genet*. [Basic Science / Preclinical]
Perry MS (2025). [PMID: 40354745](https://pubmed.ncbi.nlm.nih.gov/40354745/). *Seizure*. [Epidemiology / Natural History]
Aguilar-Amat Prior MJ (2025). [PMID: 40516368](https://pubmed.ncbi.nlm.nih.gov/40516368/). *Seizure*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:56 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
AI-curated news mentioning developmental and epileptic encephalopathy, 84
Updated Apr 16, 2026
Recent research utilizing optical genome mapping has uncovered previously undetected causal variants in early-onset developmental epileptic encephalopathies. This advancement could enhance diagnostic accuracy and treatment strategies for affected patients.